Cutaneous T-Cell Lymphoma/Mycosis Fungoides
11 clinical trials · Condition
◉ Watch Cutaneous T-Cell Lymphoma/Mycosis Fungoides
| Record | Firm | Date |
|---|---|---|
| PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma (NCT05380635) | Soligenix | 2022-05-09 |
| PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (NCT03837457) | miRagen Therapeutics, Inc. | 2019-10-01 |
| SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (NCT03713320) | miRagen Therapeutics, Inc. | 2019-04-02 |
| Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL) (NCT04702503) | Moleculin Biotech, Inc. | 2019-03-08 |
| PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides (NCT00630903) | Madrilenian Group of Cutaneous Lymphomas | 2000-01-01 |
Track Cutaneous T-Cell Lymphoma/Mycosis Fungoides automatically
Every clearance here is in the API, with alerts when new ones post.